Therefore, in the present study, we performed a meta-analysis of 13 independent case–control studies that included 5,013 cases and 4,463 controls to evaluate the association of NOD2 polymorphisms with CRC risk. The gene discussed is NOD2; the disease is colorectal carcinoma.